These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18550671)

  • 1. Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.
    Bukh J; Thimme R; Meunier JC; Faulk K; Spangenberg HC; Chang KM; Satterfield W; Chisari FV; Purcell RH
    J Virol; 2008 Aug; 82(16):8183-95. PubMed ID: 18550671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.
    Barth H; Rybczynska J; Patient R; Choi Y; Sapp RK; Baumert TF; Krawczynski K; Liang TJ
    Hepatology; 2011 Oct; 54(4):1135-48. PubMed ID: 21674561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.
    Bassett SE; Guerra B; Brasky K; Miskovsky E; Houghton M; Klimpel GR; Lanford RE
    Hepatology; 2001 Jun; 33(6):1479-87. PubMed ID: 11391537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies.
    Gottwein JM; Scheel TK; Callendret B; Li YP; Eccleston HB; Engle RE; Govindarajan S; Satterfield W; Purcell RH; Walker CM; Bukh J
    J Virol; 2010 May; 84(10):5277-93. PubMed ID: 20200247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.
    Yanagi M; St Claire M; Shapiro M; Emerson SU; Purcell RH; Bukh J
    Virology; 1998 Apr; 244(1):161-72. PubMed ID: 9581788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model.
    Prince AM; Brotman B; Lee DH; Pfahler W; Tricoche N; Andrus L; Shata MT
    J Infect Dis; 2005 Nov; 192(10):1701-9. PubMed ID: 16235167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells.
    Sakai A; Takikawa S; Thimme R; Meunier JC; Spangenberg HC; Govindarajan S; Farci P; Emerson SU; Chisari FV; Purcell RH; Bukh J
    J Virol; 2007 Jul; 81(13):7208-19. PubMed ID: 17409145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.
    Nascimbeni M; Mizukoshi E; Bosmann M; Major ME; Mihalik K; Rice CM; Feinstone SM; Rehermann B
    J Virol; 2003 Apr; 77(8):4781-93. PubMed ID: 12663785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection.
    Wyatt CA; Andrus L; Brotman B; Huang F; Lee DH; Prince AM
    J Virol; 1998 Mar; 72(3):1725-30. PubMed ID: 9499020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.
    Farci P; Alter HJ; Wong DC; Miller RH; Govindarajan S; Engle R; Shapiro M; Purcell RH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7792-6. PubMed ID: 7519785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of protective immunity against reinfection with hepatitis C virus.
    Farci P; Alter HJ; Govindarajan S; Wong DC; Engle R; Lesniewski RR; Mushahwar IK; Desai SM; Miller RH; Ogata N
    Science; 1992 Oct; 258(5079):135-40. PubMed ID: 1279801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.
    Major ME; Mihalik K; Puig M; Rehermann B; Nascimbeni M; Rice CM; Feinstone SM
    J Virol; 2002 Jul; 76(13):6586-95. PubMed ID: 12050371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
    Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
    Li YP; Ramirez S; Mikkelsen L; Bukh J
    J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a.
    Okamoto H; Mishiro S; Tokita H; Tsuda F; Miyakawa Y; Mayumi M
    Hepatology; 1994 Nov; 20(5):1131-6. PubMed ID: 7927243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity.
    Thomson M; Nascimbeni M; Havert MB; Major M; Gonzales S; Alter H; Feinstone SM; Murthy KK; Rehermann B; Liang TJ
    J Virol; 2003 Jan; 77(2):862-70. PubMed ID: 12502802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.
    Osburn WO; Fisher BE; Dowd KA; Urban G; Liu L; Ray SC; Thomas DL; Cox AL
    Gastroenterology; 2010 Jan; 138(1):315-24. PubMed ID: 19782080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia.
    Farci P; London WT; Wong DC; Dawson GJ; Vallari DS; Engle R; Purcell RH
    J Infect Dis; 1992 Jun; 165(6):1006-11. PubMed ID: 1374781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.